ESC 365 - Atrial fibrillation and hypertension: implications for clinical practice

ESC Premium Access

Atrial fibrillation and hypertension: implications for clinical practice

Event: ESC CONGRESS 2016

Topic: Hypertension, other

Session type: Symposium

Date: 28 August 2016

Time: 11:00 - 12:30

Congress Session

4 presentations in this session

Hypertensive phenotype and risk of atrial fibrillation

Speaker: Associate Professor M. Losi (Naples, IT)

ECG and circulating biomarkers to stratify atrial fibrillation risk

Speaker: Associate Professor G. Schillaci

Stroke prevention and anticoagulation in non valvular atrial fibrillation in hypertension

Speaker: Professor J. Camm (London, GB)

Drug treatment of hypertension to prevent atrial fibrillation and in patients with atrial fibrillation

Speaker: Doctor T. Aksnes (Oslo, NO)

4 speakers from this session

Associate Professor Maria-Angela Losi

Federico II University of Naples, Naples (Italy)

1 presentation

0 follower

Associate Professor Giuseppe Schillaci

, ()

4 presentations

0 follower

Professor John Camm

St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)

53 presentations

1 follower

Doctor Tonje Aksnes

Oslo University Hospital Rikshospitalet, Oslo (Norway)

1 presentation

0 follower

This platform is supported by